Using tiny particles to improve light-based treatments for diseases
NANOPHOTOSENSITIZERS FOR REGENERATIVE PHOTOTHERAPY
['FUNDING_R01'] · UT SOUTHWESTERN MEDICAL CENTER · NIH-10897691
This study is looking at new tiny particles that can help make light treatments for diseases more effective and safer by delivering medicine directly to the right spot, so patients can feel better with fewer side effects.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UT SOUTHWESTERN MEDICAL CENTER (nih funded) |
| Locations | 1 site (DALLAS, UNITED STATES) |
| Trial ID | NIH-10897691 on ClinicalTrials.gov |
What this research studies
This research focuses on developing inorganic nanoparticles that can enhance phototherapy, a treatment that uses light to target and treat diseases. By attaching drugs or imaging agents to these nanoparticles, the goal is to achieve precise targeting of affected tissues, minimizing side effects. The study explores how these nanoparticles can be transformed into energy transducers that activate upon light exposure, allowing for controlled and effective treatment. Patients may benefit from improved therapeutic outcomes with fewer off-target effects compared to traditional methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from advanced phototherapy techniques.
Not a fit: Patients who do not have conditions amenable to light-based treatments may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer light-based treatments for various diseases.
How similar studies have performed: Previous research has shown promise in using nanoparticles for targeted therapy, indicating potential success for this novel approach.
Where this research is happening
DALLAS, UNITED STATES
- UT SOUTHWESTERN MEDICAL CENTER — DALLAS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ACHILEFU, SAMUEL — UT SOUTHWESTERN MEDICAL CENTER
- Study coordinator: ACHILEFU, SAMUEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.